ASX - By Stock
|
TLX |
Re:
Ann: Telix 1H 2024 Results Presentation
|
|
turbo
|
46 |
16K |
9 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
46
|
16K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
turbo
|
76 |
24K |
72 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
76
|
24K
|
72
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
9 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
11K
|
5.3M
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Angelman
|
|
turbo
|
87 |
43K |
33 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
87
|
43K
|
33
|
|
ASX - By Stock
|
TLX |
Re:
Ann: BLA Filing Update for Renal Cancer Imaging Agent TLX250-CDx
|
|
turbo
|
69 |
24K |
9 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
69
|
24K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: BLA Filing Update for Renal Cancer Imaging Agent TLX250-CDx
|
|
turbo
|
69 |
24K |
16 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
69
|
24K
|
16
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
turbo
|
1.3K |
650K |
5 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
1.3K
|
650K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Angelman trial
|
|
turbo
|
71 |
40K |
35 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
71
|
40K
|
35
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
turbo
|
19K |
11M |
0 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
19K
|
11M
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
turbo
|
19K |
11M |
1 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
19K
|
11M
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
turbo
|
19K |
11M |
11 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
19K
|
11M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
5 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
11K
|
5.3M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren receives Rare Pediatric Disease Designation from FDA
|
|
turbo
|
32 |
15K |
9 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
32
|
15K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
89 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
11K
|
5.3M
|
89
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren receives Rare Pediatric Disease Designation from FDA
|
|
turbo
|
32 |
15K |
6 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
32
|
15K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren receives Rare Pediatric Disease Designation from FDA
|
|
turbo
|
32 |
15K |
22 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
32
|
15K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Angelman trial
|
|
turbo
|
71 |
40K |
9 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
71
|
40K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Angelman trial
|
|
turbo
|
71 |
40K |
11 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
71
|
40K
|
11
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
turbo
|
19K |
11M |
20 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
19K
|
11M
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
turbo
|
817 |
381K |
17 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
817
|
381K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
turbo
|
817 |
381K |
14 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
817
|
381K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Briefings & Webinar Notice
|
|
turbo
|
81 |
23K |
21 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
81
|
23K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Briefings & Webinar Notice
|
|
turbo
|
81 |
23K |
36 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
81
|
23K
|
36
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Afamelanotide Assists DNA Repair Response Following UVR
|
|
turbo
|
101 |
33K |
6 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
101
|
33K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
turbo
|
1.3K |
689K |
45 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
1.3K
|
689K
|
45
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
turbo
|
1.3K |
650K |
7 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
1.3K
|
650K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
turbo
|
1.3K |
689K |
7 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
1.3K
|
689K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
turbo
|
1.3K |
689K |
4 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
1.3K
|
689K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Presentation
|
|
turbo
|
91 |
24K |
3 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
91
|
24K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
turbo
|
1.3K |
689K |
38 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
1.3K
|
689K
|
38
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Presentation
|
|
turbo
|
91 |
24K |
14 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
91
|
24K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Presentation
|
|
turbo
|
91 |
24K |
17 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
91
|
24K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Competitors to Daybue
|
|
turbo
|
22 |
10K |
36 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
22
|
10K
|
36
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
10 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
35 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
35
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
5 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
24 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
11 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
turbo
|
188 |
79K |
9 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
188
|
79K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
turbo
|
188 |
79K |
34 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
188
|
79K
|
34
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
turbo
|
188 |
79K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
188
|
79K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
turbo
|
188 |
79K |
20 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
188
|
79K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
turbo
|
188 |
79K |
17 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
188
|
79K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
turbo
|
188 |
79K |
6 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
188
|
79K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
turbo
|
188 |
79K |
14 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
188
|
79K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
15 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
15
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
turbo
|
19K |
11M |
30 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
19K
|
11M
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
turbo
|
85 |
22K |
20 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
22K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
turbo
|
76 |
35K |
33 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
76
|
35K
|
33
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
turbo
|
11K |
5.3M |
31 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
11K
|
5.3M
|
31
|
|